Brief: Sienna Biopharmaceuticals reports third quarter results
08/11/2018 14:09
Nov 8 (Reuters) - Sienna Biopharmaceuticals Inc SNNA.O :
* SIENNA BIOPHARMACEUTICALS® REPORTS THIRD QUARTER 2018
FINANCIAL
RESULTS
* SIENNA BIOPHARMACEUTICALS INC - QTRLY NET LOSS PER SHARE
$0.82
* SIENNA BIOPHARMACEUTICALS INC - CASH AND CASH EQUIVALENTS
AS OF
SEPT. 30, 2018, TOTALED APPROXIMATELY $64.0 MILLION
Source text for Eikon: ID:nGNX3Hc9rd
Further company coverage: SNNA.O
((Briefs@thomsonreuters.com;))
Recent news on Sienna Biopharmaceuticals
See all newsU.S. STOCKS ON THE MOVE-Adobe, Oracle, Snap, Phreesia, Sarepta, Aquestive Therapeutics, Patterson-UTI
U.S. STOCKS ON THE MOVE-Lululemon, GE, Starbucks, Delta Air Lines, Lumber Liquidators, Lovesac
Sienna Biopharma: Falls on Nasdaq delisting plans
Brief: Sienna Biopharma Says Bankruptcy Court Approved Sale Of Assets Related To SNA-001 For $1.7 Mln In Cash
Brief: Sienna Biopharmaceuticals Announces Court Approval Of Chapter 11 Bidding Procedures